Results 101 to 110 of about 7,004 (244)

P-1868. Incidence of Rhabdomyolysis in Patients Receiving Daptomycin in a Community Hospital OPAT Program

open access: yesOpen Forum Infectious Diseases
Background Daptomycin is a favorable medication for outpatient parenteral antimicrobial therapy (OPAT) due to its low rate of serious adverse events, however one potential therapy complication is the development of rhabdomyolysis.
Allison N Cid   +6 more
semanticscholar   +1 more source

Evaluating Outpatient Parenteral Antimicrobial Therapy (OPAT) Clinic for Pediatric Infectious Conditions: Insights From Alberta Children’s Hospital

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, Volume 2026, Issue 1, 2026.
Background The Outpatient Parenteral Antimicrobial Therapy (OPAT) Clinic at the Alberta Children’s Hospital (ACH) offers a vital service, enabling stable pediatric patients to receive intravenous (IV) antimicrobial therapy on an outpatient basis.
Danah Alsharrah   +2 more
wiley   +1 more source

Outpatient parenteral ­antimicrobial therapy (OPAT) and the general ­physician [PDF]

open access: yesClinical Medicine, 2013
Outpatient parenteral antimicrobial therapy (OPAT) refers to outpatient or community-based management of an infection via the administration of an intravenous (IV) antimicrobial without an overnight hospital stay. Patients may be managed without admission or may transition to OPAT following hospitalisation.
Gavin Barlow, DA Barr, RA Seaton
openaire   +2 more sources

Stability of Nine Time-Dependent Antibiotics for Outpatient Parenteral Antimicrobial Therapy (OPAT) Use

open access: yesAntibiotics
Background: The use of an elastomeric diffuser is favored to administer outpatient antibiotic therapy. A study published in 2022 highlighted the instability of several antibiotics in elastomeric devices at 37 °C.
E. d'Huart   +5 more
semanticscholar   +1 more source

Zoonotic Streptococcus canis Bacteremia Following a Dog Scratch in an Elderly Patient With a Nonconditional Pacemaker

open access: yesCase Reports in Infectious Diseases, Volume 2026, Issue 1, 2026.
Streptococcus canis is a β‐hemolytic Group G streptococcus commonly found in the microbiome of dogs and cats and is an uncommon cause of invasive human infection. Although typically regarded as a veterinary pathogen, S. canis has been reported to cause bacteremia, endocarditis, and other severe infections in humans, particularly in older adults with ...
Kamel Alachraf   +3 more
wiley   +1 more source

A Review of β‐Lactamase Inhibitors in Clinical Use and Development: Mechanisms, Spectrum, and Therapeutic Applications

open access: yesInternational Journal of Microbiology, Volume 2026, Issue 1, 2026.
β‐Lactam antibiotics have long served as a cornerstone for treating bacterial infections. However, their widespread and often indiscriminate use has fueled the emergence of multidrug‐resistant Gram‐negative pathogens, primarily through the production and dissemination of β‐lactamase enzymes.
Mohammad Javad Roustaye Gourabi   +9 more
wiley   +1 more source

46 Unpacking OPAT Risk: Factors Associated with Adverse Clinical Outcomes in an Academic OPAT Program [PDF]

open access: yesAntimicrob Steward Healthc Epidemiol
Background: Inpatient psychiatric units (IPUs) present unique challenges for prevention of respiratory virus illness (RVI) transmissions due to shared living spaces, group-based therapeutic activities, and limited ability to isolate or mask patients. Evidence-based infection prevention (IP) strategies in these settings are limited.
Stancovici A, Rathod S, Barajas G.
europepmc   +2 more sources

The success rate and complications of midline catheters in pediatric outpatient parenteral antibiotic therapy (OPAT)

open access: yesEuropean Journal of Pediatrics
The use of outpatient parenteral antimicrobial therapy (OPAT) for children has several advantages, including reduced length of hospital stay and costs. A reliable vascular access is key to delivering safe and effective pediatric OPAT.
U. Fläring   +3 more
semanticscholar   +1 more source

Abstract Supplement

open access: yesPulmonary Medicine, Volume 2026, Issue 1, 2026.
 
Marzia Folegani, Semonti Nandi
wiley   +1 more source

Home - About - Disclaimer - Privacy